| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 耳鼻喉科用药(元) | 152,538,671.15 | 206,533,218.19 | 97,020,268.30 | 256,691,537.38 | 97,624,911.64 |
| 激素及调节内分泌功能药物(元) | - | 14,604,193.50 | - | 24,022,017.78 | 18,820,017.75 |
| 精神神经系统用药(元) | 74,307,758.63 | 131,601,111.78 | 68,231,141.73 | 122,131,582.36 | 58,422,934.77 |
| 零售(元) | 1,040,119.52 | 2,758,076.07 | 1,156,677.49 | 2,026,123.12 | 966,124.42 |
| 商业流通(元) | 66,776,290.99 | 113,881,817.73 | 61,973,889.48 | 112,640,897.39 | 60,140,663.71 |
| 消化系统用药(元) | 86,267,239.70 | 160,167,724.45 | 89,473,510.14 | 197,155,003.61 | 97,315,436.14 |
| 其他领域用药(元) | 31,687,046.72 | 51,296,306.66 | 36,796,719.76 | 60,048,493.66 | 29,227,823.18 |
| 其他业务(元) | - | - | 5,803,209.73 | 10,467,158.28 | 5,110,060.88 |
| 营业成本(元) | |||||
| 耳鼻喉科用药(元) | 30,858,950.54 | 39,921,179.40 | 16,952,145.90 | 49,362,475.87 | 17,897,504.06 |
| 激素及调节内分泌功能药物(元) | - | - | - | - | - |
| 精神神经系统用药(元) | 27,919,733.63 | 56,222,489.00 | 23,184,599.85 | 37,945,543.30 | 16,870,478.03 |
| 零售(元) | 764,553.91 | - | 922,029.55 | - | - |
| 商业流通(元) | 61,913,287.05 | 105,221,048.35 | 57,288,296.31 | 104,272,876.20 | 55,931,954.21 |
| 消化系统用药(元) | 40,091,697.09 | 77,499,076.12 | 38,036,723.35 | 83,929,665.57 | 39,210,285.21 |
| 其他领域用药(元) | 12,197,799.33 | - | 14,578,979.97 | - | - |
| 其他业务(元) | - | - | 3,486,117.35 | 3,946,366.33 | 2,027,612.90 |
| 毛利(元) | |||||
| 耳鼻喉科用药(元) | 121,679,720.61 | 166,612,038.79 | 80,068,122.40 | 207,329,061.51 | 79,727,407.58 |
| 激素及调节内分泌功能药物(元) | - | - | - | - | - |
| 精神神经系统用药(元) | 46,388,025.00 | 75,378,622.78 | 45,046,541.88 | 84,186,039.06 | 41,552,456.74 |
| 零售(元) | 275,565.61 | - | 234,647.94 | - | - |
| 商业流通(元) | 4,863,003.94 | 8,660,769.38 | 4,685,593.17 | 8,368,021.19 | 4,208,709.50 |
| 消化系统用药(元) | 46,175,542.61 | 82,668,648.33 | 51,436,786.79 | 113,225,338.04 | 58,105,150.93 |
| 其他领域用药(元) | 19,489,247.39 | - | 22,217,739.79 | - | - |
| 其他业务(元) | - | - | 2,317,092.38 | 6,520,791.95 | 3,082,447.98 |
| 毛利率(%) | |||||
| 耳鼻喉科用药(%) | 79.77 | 80.67 | 82.53 | 80.77 | 81.67 |
| 激素及调节内分泌功能药物(%) | - | - | - | - | - |
| 精神神经系统用药(%) | 62.43 | 57.28 | 66.02 | 68.93 | 71.12 |
| 零售(%) | 26.49 | - | 20.29 | - | - |
| 商业流通(%) | 7.28 | 7.61 | 7.56 | 7.43 | 7.00 |
| 消化系统用药(%) | 53.53 | 51.61 | 57.49 | 57.43 | 59.71 |
| 其他领域用药(%) | 61.51 | - | 60.38 | - | - |
| 其他业务(%) | - | - | 39.93 | 62.30 | 60.32 |
| 收入构成(%) | |||||
| 耳鼻喉科用药(%) | 36.97 | 30.33 | 26.92 | 32.69 | 26.56 |
| 激素及调节内分泌功能药物(%) | - | 2.15 | - | 3.06 | 5.12 |
| 精神神经系统用药(%) | 18.01 | 19.33 | 18.93 | 15.55 | 15.89 |
| 零售(%) | 0.25 | 0.41 | 0.32 | 0.26 | 0.26 |
| 商业流通(%) | 16.18 | 16.73 | 17.19 | 14.35 | 16.36 |
| 消化系统用药(%) | 20.91 | 23.52 | 24.82 | 25.11 | 26.47 |
| 其他领域用药(%) | 7.68 | 7.53 | 10.21 | 7.65 | 7.95 |
| 其他业务(%) | - | - | 1.61 | 1.33 | 1.39 |
| 毛利构成(%) | |||||
| 耳鼻喉科用药(%) | 50.94 | 49.99 | 38.87 | 49.41 | 42.71 |
| 激素及调节内分泌功能药物(%) | - | 0.00 | - | 0.00 | 0.00 |
| 精神神经系统用药(%) | 19.42 | 22.61 | 21.87 | 20.06 | 22.26 |
| 零售(%) | 0.12 | 0.00 | 0.11 | 0.00 | 0.00 |
| 商业流通(%) | 2.04 | 2.60 | 2.27 | 1.99 | 2.25 |
| 消化系统用药(%) | 19.33 | 24.80 | 24.97 | 26.98 | 31.13 |
| 其他领域用药(%) | 8.16 | 0.00 | 10.78 | 0.00 | 0.00 |
| 其他业务(%) | - | - | 1.12 | 1.55 | 1.65 |